World first:Celiac disease VACCINE trialed in Australia! Gluten Intolerant

be excited!for a few short days. The T cells in blood can be
monitored and analyzed to define what part of
Will the CELIAC VACCINE provide a complete CDgluten they recognize. The parts of gluten
CURE? If you are celiac or gluten sensitive andrecognized by the vast majority of T cells
were told that there is a ‘cure' for yourinvolved in celiac disease can be condensed to a
disease, would you take it if there were few sidefew "short" fragments of gluten that remain after
effects? Most people with celiac disease wouldits digestion in the gut. These gluten fragments
answer an instantaneous yes, however there arecan be synthesized using fairly standard chemistry
several important issues to consider in thisand are the basis for the celiac vaccine."
panacea.The Celiac Vaccine Trials
If you are a celiac, your miracle cure is underThe original research began at Oxford England in
way - being trialed in Melbourne Australia from1997. The work continued in Australia in 2002 and
April 2009! It could conceivably desensitize peopleby April 2009 Bob Anderson from the Walter and
with celiac disease to the point that the villi in theirEliza Hall Institute of Medical research (Melbourne,
small intestine are not damaged by the glutenAustralia) will commence the first world trials of a
protein. However with the need for extensiveceliac vaccine that could reduce or eradicate the
testing in this three phase trial, the vaccine mayneed for being gluten free. In fact Bob Anderson
not be ready for release for several years.calls the vaccine a "next-generation desensitization
Before we go into the details of such a cure ittherapy" that has been successful in mice and is
should be noted that this vaccine might not be asoon to be tested on celiacs.
‘magic bullet' that makes people permanently"The vaccine will be tested on 40 volunteers with
immune to the gluten protein, it might 'only'celiac disease over 11 months to establish that it
desensitize them. Also be aware that if youdoes not harm them. In a subsequent phase 2
choose to undertake the ‘therapy' there aretrial, which is designed to find out if the treatment
no guarantees of how you will react, and the onlyis effective, volunteers will receive the treatment
way to regularly check to see if you have beenand then be challenged with foods containing
‘cured' would be regular intestine biopsies. As itgluten. Their immune response and intestines will
is known that some people take over two yearsthen be examined to see if a tolerance to gluten
to heal their intestines from gluten damage, howhas developed. The therapy involves repeatedly
risky will this strategy be? It is expected thatinjecting solutions of gluten at increasing
testing will be extensive so these questions mayconcentrations. The aim is to desensitize the
all sit under the ‘devil's advocate' category, andsubjects slowly, in a similar way to hay fever and
all may be well.dust allergy desensitization treatments."
An even more philosophical question is whatTesting process
effect covering up the cause of your disease will"For a new drug to be accepted for use in people
have on your body. Books have been writtenin Australia, Europe, or North America it must
that suggest that it is the increased glutenhave progressed successfully from Phase 1
potency in wheat and other gluten grains as well(safety) studies usually involving up to about 30
as increased use in manufactured foods that hasvolunteers, to Phase 2 (efficacy) studies to show
led to an overdose of gluten. Our bodies thenthat "it works" in people with the medical condition
pass a ‘tipping point' where our geneticof interest (typically about 200 volunteers in
predisposition to CD turns into an active disease.several locations around the world), and to Phase
If this is true, how wise would it be to continue3 (similar to Phase 2 but involving several
ingesting unnaturally high levels of gluten, oncethousand volunteers in many sites around the
‘cured' just because we can? Sure it wouldworld)."
make life simpler not following a gluten free diet,The celiac vaccine future
however maybe we should wait for gluten to beDue to difficulties in funding, Bob Anderson
decreased at the source, the growing fields,(Walter and Eliza Hall Institute) co-founded a
before we return to a gluten filled diet.commercial company called Nexpep to develop
Different types of celiac disease identifiedthe vaccine. Nucleus Network, Centre for Clinical
With all these issues under consideration, I amStudies (CCS) in the Alfred Hospital in Melbourne,
sure that every celiac would still be interested in awill be conducting the Phase 1 clinical trial.
‘cure'. A July 2007 article based on researchThe difficulty he has faced, besides the technical
conducted in Victoria, Australia, showed thatissues, is the low diagnosis level of celiac disease
"Celiac disease - is strongly associated with humanand the mass of associated symptoms has made
leukocyte antigen (HLA) DQ2 and to a lessera vaccine cure unattractive to traditional
extent with HLA DQ8."pharmaceutical companies. These companies
"HLA genes are part of the majoralways prefer well defined markets to accurately
histocompatibility complex (MHC), which plays aforecast payback periods for their R&D and
pivotal role in the immune system. HLA-DQ2marketing expenses.
mediated celiac disease is common in people ofThe facts are that for this vaccine to prove
European ancestry, with about 90 per cent offinancially viable, The US will need to approve the
sufferers positive for DQ2. Another five per centdrug and doctors and celiacs will need to accept
possess HLA DQ8. In China and East Asia, DQ2the treatment. One report estimates that only
genes are rare while DQ8 genes are as common600,000 people are diagnosed with celiac disease
as in Europe."(out of the 5 million with celiac disease in North
So it appears that this preliminary research hasAmerica and Europe).  
been able to isolate two main versions of celiacCompounded to the funding challenges is that
disease. However the molecular workings of thepreviously, globally, there have only been three
immune response in the two antigens appear to"randomized, controlled" studies of the gluten free
be very different. The researchers discovereddiet - one in children and two in adults - the
that T-cells in people with DQ8-associated celiaclargest with 57 participants."
disease reacted quite differently to the smallThe assessment of the vaccine treatment will
proteins in gluten than the T-cells in people withrequire repeated endoscopy and collection of small
the DQ2 form of the disease.intestine biopsies which are expensive and
"At the moment a gluten-free diet is the onlyun-enjoyable for volunteers. However a recent
treatment for celiac disease but nearly half thetrial in Italy has shown that biopsies are still the
people on the diet still have damage to their smallonly ‘almost' guaranteed method of assessing
intestine. Consequently other therapies, including agluten damage. The study findings showed that
vaccine and three different drugs, are in various"two years after adopting a gluten free diet,
stages of development. The research teamabout half those people diagnosed with celiac
believes celiac disease might be the first exampledisease continued to have villous atrophy as
of an immune disease where treatments aresevere as when they were first diagnosed. Only
customized according to the genetic make-up ofabout one in five of those with severe intestinal
the patient."damage (villous atrophy) on a gluten free diet had
The celiac vaccine discoveryraised (abnormal) blood levels of transglutaminase
The discovery that lead to the creation of theantibody, meaning that standard blood tests to
vaccine was that the one critical part of wheatmonitor disease activity were relatively
gluten protein that was toxic was the commonineffective."
genetic version (HLA DQ2) of celiac disease. "AsSo while the development of this vaccine is an
much as the identity of the toxic component ofimportant step in potentially eradicating celiac
gluten was important, it was the way in which itdisease, philosophical questions still remain as
was found that has proven to be even moreissues for the long term efficacy of the vaccines.
important. By eating gluten in wheat, rye, orAs an Australian first, this research is applauded
barley for three days (even a single meal willby the gluten free community. We wish the
suffice in some people), immune cells (T cells) thatresearchers and medical staff all of the best in
damage the small intestine are mobilized into blooddemystifying this illusive disease.